Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369467
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-04-11
Brief Title:
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E IgE-Mediated Food Allergy
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals